Yixintang Pharmaceutical Group...
SZSE:002727
¥ 22.65
¥-0.09 (-0.40%)
¥ 22.65
¥-0.09 (-0.40%)
End-of-day quote: 05/17/2024

Yixintang Pharmaceutical Group financials at a glance

The revenue of Yixintang Pharmaceutical Group is reported as 18.3269 billion Yuan Renminbi in the fiscal year 2023. The earnings were 1.69 Yuan Renminbi per share in 2023, which was 1.2 higher than 2022. And about 1.85687 billion Yuan Renminbi are reported as free cash flow in the financials of Yixintang Pharmaceutical Group 2023. Dividends of 0.23 Yuan Renminbi per share were paid to shareholders of Yixintang Pharmaceutical Group stock SZSE:002727 in fiscal 2023.

¥18.33B
Revenue
¥1.69
Earnings Per Share
100.00%
Gross Margin %
¥14.00M
Free Cash Flow
Revenue
18,326.90
Earnings Per Share
1.69
Gross Margin %
100.00
Free Cash Flow
14.00

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2015 2014 2013
Rev. Revenue N/A ¥18.33B ¥17.43B ¥14.59B ¥12.66B ¥10.48B ¥9.18B ¥5.32B ¥4.43B ¥0.00M
GM % Gross Margin % 32.61% 100.00% 34.05% 36.11% 35.13% 38.10% 39.63% 40.78% 38.77% 0.00%
OM Operating Margin 7.41% 4.52% 7.56% 8.13% 7.11% 7.25% 7.85% 7.19% 7.85% 0.00%
EPS Earnings Per Share ¥1.71 ¥1.69 ¥1.67 ¥1.52 ¥1.32 ¥1.04 ¥0.90 ¥0.63 ¥0.65 ¥0.62
Div. Dividends N/A ¥0.23 ¥0.40 ¥0.30 ¥0.30 ¥0.30 ¥0.30 ¥0.25 ¥0.30 ¥0.00
PR % Payout Ratio % 0 13.61% 23.95% 19.74% 22.73% 28.85% 33.33% 39.68% 46.15% 0
Sha. Shares N/AM 596.01M 596.02M 596.18M 595.31M 567.77M 567.77M 520.6M 520.6M 390.4M
OCF Operating Cash Flow N/A ¥1.86B ¥2.50B ¥1.79B ¥1.03B ¥982.92M ¥635.77M ¥185.76M ¥176.22M ¥0.00M
FCF Free Cash Flow N/A ¥14.00M ¥2.15B ¥1.40B ¥753.18M ¥777.44M ¥479.95M ¥-,358.00M ¥17.59M ¥0.00M
FCFS Free Cash Flow Per Share ¥3.31 ¥0.00 ¥3.62 ¥2.37 ¥1.32 ¥1.37 ¥0.84 ¥-0.02 ¥0.04 ¥0.00